[Inhalation therapy using secretolytics].
D000111:Acetylcysteine / Q000008:administration & dosage* / Q000009:adverse effects; D000403:Airway Resistance; D000643:Ammonium Chloride / Q000008:administration & dosage* / Q000009:adverse effects; D001784:Blood Gas Analysis; D003902:Detergents / Q000008:administration & dosage; D006294:Health Resorts; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D009822:Oils, Volatile / Q000008:administration & dosage* / Q000009:adverse effects; D010993:Plethysmography, Whole Body; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D013997:Time Factors
D003902:Detergents; D009822:Oils, Volatile; D000643:Ammonium Chloride; D000111:Acetylcysteine
Inhalationstherapie mit Sekretolytika.